Avantect Cancer
Detection Kit
Request Form

Avantect Cancer Detection Kit Request Form

Thank you for your interest in our tests. Please note the following before submitting the form below for a test kit to be delivered to your address.

  • The Avantect test is now available for both pancreatic cancer detection and ovarian cancer detection.
  • Your kit will have all the information needed for you to take it to your physician to order the test.
  • A simple blood draw will be required. We have additional information online to help you with this process following your physician’s direction and signature on the ordering form.
  • While the kit will cost you nothing to order, the fee to run the test will be $1,445. We will pursue reimbursement on your behalf, and we have a patient assistance program that you will be able to access. Further information is available on our website for U.S. patients.


Once you receive the kit, you will need to bring the Avantect kit and test form to your provider for signature and then schedule a blood draw at www.avantect.com/blood-draw.

Important information

The Avantect Pancreatic Cancer and Ovarian Cancer Tests are early detection tests and do not establish a diagnosis of cancer. Results should be considered in the context of other clinical criteria. Definitive diagnosis of pancreatic or ovarian cancer usually requires a series of imaging scans, blood tests, and a biopsy. Not all pancreatic or ovarian cancers will be detected. Some patients with pancreatic or ovarian cancer may have a “Signal not detected” result. Some patients without pancreatic or ovarian cancer may have a “Signal detected” result. False-negative and false-positive results are possible. A “Signal not detected” result does not guarantee that no pancreatic or ovarian cancer is present. In some cases, no result is obtained. While this is very uncommon, it may be caused by shipping delays or when there is not enough cell-free DNA for the test in the patient’s blood. If this happens, we generally ask for a repeat blood sample for testing at no extra cost.

The test was developed in the ClearNote Health CLIA-certified (CLIA# 05D2249973) and CAP-accredited (CAP# 9219174) laboratory and has not been cleared or approved by the US Food and Drug Administration (FDA).